Ethical Conduct of Radiology Research With Human Participants

Journal of the American College of Radiology

Volumn 3, Issue 12, 2006, Pages 932-939

  Burger, Ingrid ^a   Kass, Nancy ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Ethics; federal regulations; human subjects research; informed consent

Indexed keywords

ARTICLE; EXPERIMENTAL THERAPY; HUMAN; INCIDENTAL FINDING; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; MEDICAL RESEARCH; OUTCOMES RESEARCH; PRACTICE GUIDELINE; RADIOLOGICAL PROCEDURES; RADIOLOGY; RESEARCH SUBJECT; VOLUNTEER;

EID: 84928096559     PISSN: 15461440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacr.2006.06.010     Document Type: Article

References (45)

1. National Commission for the Protections of Human Subjects of Biomedical and Behavioral Research. The Belmont report: ethical principles and guidelines for the protection of human subjects of research (1979), National Commission for the Protections of Human Subjects of Biomedical and Behavioral Research, Washington, DC
2. Protection of human subjects: federal policy for the protection of human subjects. Code of Federal Regulations (Title 45, Part 46). 1991.
3. Advisory Committee on Human Radiation Experiments. The human radiation experiments: final report of the President's Advisory Committee on Human Radiation Experiments (1996), Oxford University Press, New York, NY
4. Emanuel E.J., Wendler D., and Grady C. What makes clinical research ethical?. JAMA 283 (2000) 2701-2711
5. Wadey V., and Frank C. The effectiveness of patient verbalization on informed consent. Can J Surg 40 (1997) 124-128
6. Sorrell J.M. Effects of writing/speaking on comprehension of information for informed consent. West J Nurs Res 13 (1991) 110-122
7. Combs D.R., Adams S.D., Wood T.D., Basso M.R., and Gouvier W.D. Informed consent in schizophrenia: the use of cues in the assessment of understanding. Schizophr Res 77 (2005) 59-63
8. Protection of human subjects. Code of Federal Regulations (Title 21, Part 50). 2002.
9. IRB review of research: institutional review boards. Code of Federal Regulations (Title 21, Part 56). 2002.
10. Cooper J.A. Responsible conduct of radiology research: part I. The regulatory framework for human research. Radiology 236 (2005) 379-381
11. Cooper J.A. Responsible conduct of radiology research: part II. Regulatory requirements for human research. Radiology 236 (2005) 748-752
12. Cooper J.A. Responsible conduct of radiology research: part III. Exemptions from regulatory requirements for human research. Radiology 237 (2005) 3-7
13. Vick C.C., Finan K.R., Kiefe C., Neumayer L., and Hawn M.T. Variation in institutional review processes for a multisite observational study. Am J Surg 190 (2005) 805-809
14. Christian M.C., Goldberg J.L., Killen J., et al. A central institutional review board for multi-institutional trials. N Engl J Med 346 (2002) 1405-1408
15. Cobb L., Thomas G., and Dillard D. An evaluation of internal-mammary-artery ligation by a double-blind technic. N Engl J Med 260 (1959) 1115-1118
16. Dimond E.G., Kittle F., and Crockett J. Comparison of internal mammary artery ligation and sham operations for angina pectoris. Am J Cardiol 5 (1960) 483-486
17. The EC/IC Bypass Study Group. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke: results of an international randomized trial. N Engl J Med 313 (1985) 1191-1200
18. Mello M.M., and Brennan T.A. The controversy over high-dose chemotherapy with autologous bone marrow transplant for breast cancer. Health Aff (Millwood) 20 (2001) 101-117
19. Levine R. Ethics and regulation of clinical research. 2nd ed (1986), Urban & Scharzenberg, Baltimore, Md
20. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 317 (1987) 141-145
21. Hellman S., and Hellman D.S. Of mice but not men. Problems of the randomized clinical trial. N Engl J Med 324 (1991) 1585-1589
22. Miller P.B., and Weijer C. Rehabilitating equipoise. Kennedy Inst Ethics J 13 (2003) 93-118
23. Ellenberg S.S., and Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases. Ann Intern Med 133 (2000) 464-470
24. Fried C. Medical experimentation: personal integrity and social policy (1974), Amsterdam, the Netherlands
25. Tcheng J.E., Madan M., O'Shea J.C., et al. Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention. J Interv Cardiol 16 (2003) 97-105
26. Pelletier G., Ducreux M., Gay F., et al. Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 29 (1998) 129-134
27. Llovet J.M., Real M.I., Montana X., et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 (2002) 1734-1739
28. Yuen M.F., Chan A.O., Wong B.C., et al. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Am J Gastroenterol 98 (2003) 1181-1185
29. Temple R., and Ellenberg S.S. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. Ann Intern Med 133 (2000) 455-463
30. Emanuel E.J., and Miller F.G. The ethics of placebo-controlled trials-a middle ground. N Engl J Med 345 (2001) 915-919
31. Appelbaum P.S., Rothe L., Lidz C., Benson P., and Winslade W. False hopes and best data. Hastings Cent Rep 17 (1987) 20-24
32. Daugherty C., Ratain M.J., Grochowski E., et al. Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 13 (1995) 1062-1072
33. Sugarman J., Kass N.E., Goodman S.N., Perentesis P., Fernandes P., and Faden R.R. What patients say about medical research. IRB 20 (1998) 1-7
34. Meropol N.J., Weinfurt K.P., Burnett C.B., et al. Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol 21 (2003) 2589-2596
35. Weinfurt K.P., Sulmasy D.P., Schulman K.A., and Meropol N.J. Patient expectations of benefit from phase I clinical trials: linguistic considerations in diagnosing a therapeutic misconception. Theor Med Bioeth 24 (2003) 329-344
36. National Bioethics Advisory Commission. Research involving human biological materials: ethical issues and policy guidance, vol 1 (1999), National Bioethics Advisory Commission, Washington, DC
37. Johns Hopkins Bloomberg School of Public Health, Committee on Human Research. Disclosure of test results to subjects. Available at: http://www.jhsph.edu/chr/PolicyGuidelines/pandp/OTT-9.pdf.
38. Furman R. Genetic test results and the duty to disclose: can medical researchers control liability?. Seattle Univ Law Rev 23 (1999) 391-429
39. Katzman G.L., Dagher A.P., and Patronas N.J. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA 282 (1999) 36-39
40. Kim B.S., Illes J., Kaplan R.T., Reiss A., and Atlas S.W. Incidental findings on pediatric MR images of the brain. Am J Neuroradiol 23 (2002) 1674-1677
41. Illes J., Desmond J.E., Huang L.F., Raffin T.A., and Atlas S.W. Ethical and practical considerations in managing incidental findings in functional magnetic resonance imaging. Brain Cogn 50 (2002) 358-365
42. Illes J., Kirschen M.P., Karetsky K., et al. Discovery and disclosure of incidental findings in neuroimaging research. J Magn Reson Imaging 20 (2004) 743-747
43. Partridge A.H., Wong J.S., Knudsen K., et al. Offering participants results of a clinical trial: sharing results of a negative study. Lancet 365 (2005) 963-964
44. Partridge A.H., Burstein H.J., Gelman R.S., Marcom P.K., and Winer E.P. Do patients participating in clinical trials want to know study results?. J Natl Cancer Inst 95 (2003) 491-492
45. Kirschen M.P., Jaworska A., and Illes J. Subjects' expectations in neuroimaging research. J Magn Reson Imaging 23 (2006) 205-209